The Use of Cinoxacin in Urinary Tract Infections

  • Alan H. Bennett
Part of the Chemotherapy book series (CT, volume 5)


Cinoxacin, a synthetic organic compound with cinnoline(1–2 benzodiazine) as the basic ring structure has been shown to have a broad antibacterial spectrum, particularly against gram negative bacteria that are most frequently isolated from the urinary tract (1). Administered orally the compound was bactericidal at concentrations close to the minimal inhibitory concentration values. In vivo, doses required for successful therapy were comparable to those for nalidixic acid. Cinoxacin is less bound by human serum proteins than nalidixic acid, has similar antibacterial activity but appears to cause less resistence after treatment.


Urinary Tract Infection Minimal Inhibitory Concentration Nalidixic Acid Proteus Mirabilis Asymptomatic Bacteriuria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Wick, N.E., Preston, D.A., Wgite, W.A. and Gordee, R.S. Compound 64716, A New Synthetic Antibacterial Agent. Antimicrobial Agents and Chemotherapy, 4: 415, 1973.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Alan H. Bennett
    • 1
  1. 1.Harvard Medical SchoolBostonUSA

Personalised recommendations